Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
52
days
ACSL5 drives pancreatic ductal adenocarcinoma by suppressing mitophagy and enhancing ferroptosis resistance via the JAK1-STAT1-OASL axis
AuthorsJingjing Dong; Mengting Dai; Yiming Zhou; Mengde Wu; Wei Wu; Linling Zhou; Zhaoyang Ji; Tongtong Ye; Jiaying Qin; Jialu Luo; Chenhuan Yu; Mingzhi Xu
AffiliationsDepartment of General Medicine, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China; Department of Hepatopancreatobiliary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China; Department of Information Engineering, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China; Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China; Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China; Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang, 310018, China
118
days
Adaptor AP4M1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis through USP15-mediated deubiquitination and MINK1-dependent phosphorylation
AuthorsYuanhao Peng; Kuo Kang; Xuanxuan Li; Minmin Xiang; Yanling Zhou; Shuang Liu; Desheng Xiao; Hong Zhu; Yongguang Tao; Yangying Zhou
AffiliationsDepartment of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Oncology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, China
119
days
Regulation of ubiquitination and degradation of the gap junction channel protein Connexin43 involves the concerted action of multiple members of the NEDD4 family of E3 ubiquitin ligases
AuthorsMax Zachrisson Totland; Nikoline Lander Rasmussen; Vilde Cecilie Wivestad Elster; Karen Irene Arnesen; Dina Glømmi Bergmann; Ida Bergill; Jakob Mørkved Stenersen; Mathias Larsen; Joachim Jordal Moe; Sebastian Basing; Vigdis Sørensen; Trond Aasen; Edward Leithe
AffiliationsDepartment of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, 0379, Norway; Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, 0379, Norway; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, 0379, Norway; Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, 0379, Norway; Translational Molecular Pathology, Vall d’Hebron Institute of Research (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d’Hebron (IIS IR-HUVH), CIBERONC, Instituto de Salud Carlos III, Barcelona, Spain
130
days
Adrenergic stimulation of bone marrow immunity differentially affects myeloma growth and immunotherapy responses
AuthorsHatice Satilmis; Emma Verheye; Sylvia Faict; Robbe Heestermans; Ann De Becker; Karin Vanderkerken; Elke De Bruyne; Eline Menu; Erica K. Sloan; Kim De Veirman
AffiliationsTranslational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Hematology Department, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels, 1090, Belgium; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia
160
days
Arginine methyltransferase PRMT3 suppresses tumor-intrinsic immunity via promoting cGAS methylation
AuthorsYu Chen; Yang Liu; Jianfeng Peng; Xiaolong Wang; Zhonghui Wei; Xiaoyan Yin; Xueying Zhai; Yankang Li; Jinming Yu; Xiangjiao Meng
AffiliationsDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Cheeloo College of Medicine, Shandong University Cancer Center, Jinan, Shandong, China; Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Beijing, China
155
days
Preclinical evaluation of trastuzumab deruxtecan in a new HER2+ leptomeningeal colonization model
AuthorsDinesh Kumar; Vanesa Silvestri; Elijah F. Edmondson; Imran Khan; Wei Zhang; Debbie Wei; Christina Robinson; Alexandra S. Zimmer; Stanley Lipkowitz; Simone Difilippantonio; Patricia S. Steeg
AffiliationsWomen's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA; Animal Research Technical Support, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA; Molecular Histopathology Lab, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
176
days
USP22 enhances mitochondrial biogenesis via stabilizing MYBBP1A in non-small cell lung cancer
AuthorsYue Sun; Fang Zhen; Hongyi Wang; Huiyuan Tian; Le Wang; Zhanpeng Liu; Jing Hu
AffiliationsDepartment of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, No. 150 Haping Road, Harbin, Heilongjiang Province, 150040, China
218
days
Loss of PBRM1 accelerates pancreatic cancer progression by inducing acquisition of mesenchymal phenotype and inflammatory cancer-associated fibroblasts reprogramming
AuthorsJin Li; Risheng Que; Jian Zhang; Ke Ma; Shouliang Guo; Liang Wen; Jianhui Zhao; Wen Chen; Xun Wang; Hao Qin; Danfeng Qian; Jinyan Huang; Yali Xie; Tao Wei; Tingbo Liang
AffiliationsDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, Zhejiang, 310003, China; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, 310014, China
267
days
FGFR4 suppresses antitumor immunity and cuproptosis by disrupting CYLD-mediated stabilization of STING and FDX1
AuthorsHongguang Zhong; Ruixuan Huang; Wenyuan Deng; Ruiwen Ruan; Xiaofeng Dai; Chunye Huang; Qinru Zeng; Zhipeng Wu; Qin Wen; Quan Liao; Li Li; Jianping Xiong; Wan Lei; Yangyang Yao; Jun Deng
AffiliationsDepartment of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China; Department of Thoracic Surgery, The First Affiliated Hospital , Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China; Department of Radiation Oncology, Jiangxi Cancer Hospital, Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330029, China; Department of Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China; Postdoctoral Research Station, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China
151
days
The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer
AuthorsYuning Liao; Shusha Yin; E-ying Peng; Jinjie Wu; Yu Yao; Wanying He; Hongbiao Huang; Qing Liu; Yuanfei Deng; Leyi Yao; Gengxi Cai
AffiliationsGuangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, China; Department of Pathology, The First People's Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Guangdong, 528000, China; Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524000, China; Department of Breast Surgery, The First People's Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Guangdong, 528000, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days